Home/Pipeline/Cologuard

Cologuard

Colorectal Cancer Screening

CommercialMarket Leading

Key Facts

Indication

Colorectal Cancer Screening

Phase

Commercial

Status

Market Leading

Company

Exact Sciences

About Exact Sciences

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of cancer through innovative screening technologies. The company's flagship product, Cologuard, revolutionized colorectal cancer screening by providing a convenient at-home alternative to traditional colonoscopy. Through strategic acquisitions and internal development, Exact Sciences has built a comprehensive cancer diagnostics portfolio spanning screening, early detection, and personalized treatment guidance across multiple cancer types.

View full company profile

Therapeutic Areas

Oncology Cancer Screening Molecular Diagnostics Precision Medicine

Other Colorectal Cancer Screening Drugs

Drug	Company	Phase	Status
ColoClear by Circle	Prenetics	Approved/Commercial	Active
ColoAlert®	Mainz Biomed	Pivotal Study	Active (ReconAAsense Trial Ongoing)
ColoAlert® (eAArly DETECT)	Mainz Biomed	Clinical Validation	Active